Loading...
•
Mar 31, 2024
Humana Q1 2024 Earnings Report
Humana's financial performance was reported for Q1 2024, with GAAP EPS at $6.11 and Adjusted EPS at $7.23. The company revised its FY 2024 EPS guidance to approximately $13.93 on a GAAP basis, while affirming Adjusted EPS of approximately $16.00.
Key Takeaways
Humana reported its Q1 2024 financial results, with a GAAP EPS of $6.11 and an adjusted EPS of $7.23. The company has revised its full-year 2024 EPS guidance on a GAAP basis but affirmed its adjusted EPS guidance. They also raised their individual Medicare Advantage annual membership growth expectations.
Reported 1Q24 earnings per share (EPS) of $6.11 on a GAAP basis, Adjusted EPS of $7.23.
Revised FY 2024 EPS guidance to 'approximately $13.93' on a GAAP basis, while affirming Adjusted EPS of 'approximately $16.00'; affirms FY 2024 Insurance segment benefit ratio of approximately 90 percent.
Raised 2024 individual Medicare Advantage annual membership growth by 50,000 to now anticipate annual growth of approximately 150,000, or 2.8 percent.
Continues successful track record of organic expansion in Medicaid with recent contract wins in Florida, Texas, and Virginia.
Revenue by Segment
Forward Guidance
Humana revised its GAAP EPS guidance for the year ending December 31, 2024 (FY 2024) to approximately $13.93 from approximately $14.87, while affirming its Adjusted EPS guidance of approximately $16.00.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...